Literature DB >> 12481979

The metabolic basis of arginine nutrition and pharmacotherapy.

N E Flynn1, C J Meininger, T E Haynes, G Wu.   

Abstract

As an essential precursor for the synthesis of proteins and other molecules with enormous biological importance (including nitric oxide, urea, ornithine, proline, polyamines, glutamate, creatine, agmatine, and dimethylarginines), arginine displays remarkable metabolic and regulatory versatility. Evidence available to date provides a sound reason to classify arginine as an essential amino acid for young mammals (including parenterally fed human infants) and as a conditionally essential amino acid for adults under such conditions as trauma, burn injury, massive small-bowel resection, and renal failure. Arginine administration reverses endothelial dysfunction, enhances wound healing, prevents the early stages of tumorigenesis, and improves cardiovascular, reproductive, pulmonary, renal, digestive, and immune functions. Arginine or its effective precursor citrulline may hold great promise as a nutritional or pharmacotherapeutic treatment for a wide array of human diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481979     DOI: 10.1016/s0753-3322(02)00273-1

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  52 in total

1.  Does pharmacological dose of parenteral arginine have beneficial effect in rats with sub-acute peritonitis?

Authors:  Hui-Chen Lo; Shih-Chi Wu; Yao-Horng Wang; Chien-Hsing Lee
Journal:  Pediatr Surg Int       Date:  2010-02-24       Impact factor: 1.827

Review 2.  Evidence for altered placental blood flow and vascularity in compromised pregnancies.

Authors:  Lawrence P Reynolds; Joel S Caton; Dale A Redmer; Anna T Grazul-Bilska; Kimberly A Vonnahme; Pawel P Borowicz; Justin S Luther; Jacqueline M Wallace; Guoyao Wu; Thomas E Spencer
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

Review 3.  Recent advances in arginine metabolism: roles and regulation of the arginases.

Authors:  Sidney M Morris
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

4.  Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.

Authors:  E B Marliss; S Chevalier; R Gougeon; J A Morais; M Lamarche; O A J Adegoke; G Wu
Journal:  Diabetologia       Date:  2005-12-21       Impact factor: 10.122

5.  Hyperpolarized [6-13C,15N3]-Arginine as a Probe for in Vivo Arginase Activity.

Authors:  Andrew Cho; Roozbeh Eskandari; Kristin L Granlund; Kayvan R Keshari
Journal:  ACS Chem Biol       Date:  2019-03-27       Impact factor: 5.100

6.  L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.

Authors:  Lusliany J Rondón; M C Farges; N Davin; B Sion; A M Privat; M P Vasson; A Eschalier; C Courteix
Journal:  Eur J Nutr       Date:  2017-07-19       Impact factor: 5.614

7.  Maternal arginine supplementation enhances thermogenesis in the newborn lamb.

Authors:  Sorin M McKnight; Rebecca M Simmons; Guoyao Wu; M Carey Satterfield
Journal:  J Anim Sci       Date:  2020-05-01       Impact factor: 3.159

8.  Arginase blockade protects against hepatic damage in warm ischemia-reperfusion.

Authors:  Geetha Jeyabalan; John R Klune; Atsunori Nakao; Nicole Martik; Guoyao Wu; Allan Tsung; David A Geller
Journal:  Nitric Oxide       Date:  2008-04-14       Impact factor: 4.427

9.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

10.  Effect of 30% nutrient restriction in the first half of gestation on maternal and fetal baboon serum amino acid concentrations.

Authors:  Thomas J McDonald; Guoyao Wu; Mark J Nijland; Susan L Jenkins; Peter W Nathanielsz; Thomas Jansson
Journal:  Br J Nutr       Date:  2012-10-09       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.